Dan Kemp CEO at Shinobi Therapeutics

Shinobi Therapeutics Receives $59M Grant from Japanese Agency for Medical Research and Development

Shinobi Therapeutics, a trailblazer in immune evasive iPS cell therapies, has been awarded up to $59 million in non-dilutive grant funding by the Japanese Agency for Medical Research and Development (AMED). This significant grant will accelerate the development of Shinobi’s pioneering iPS-T cell therapy, aimed at treating GPC3+ solid tumors. Dr. Yasumichi Hitoshi, Chief of…

Read More
Stacey Pugh, CEO of Endogenex

Endogenex Secures $88 Million in Series C Funding to Advance Breakthrough Diabetes Treatment

Endogenex, a pioneering clinical-stage medical device company dedicated to transforming diabetes care, has successfully closed an oversubscribed Series C financing round, raising a remarkable $88 million. This substantial funding boost will propel the company towards completing its pivotal ReCET Clinical Study, a critical step in bringing their innovative ReCET™ System to market for patients suffering…

Read More

Cartken Secures $22.5M Funding to Pioneer Autonomous Navigation Technology

Cartken, a trailblazing robotics navigation software startup founded in Germany, has announced a significant funding milestone, raising $22.5 million to propel its advancements in autonomous navigation. The latest financing round, including a substantial $10 million injection, underscores Cartken’s commitment to revolutionizing industrial automation and last-mile delivery solutions. Cartken’s cutting-edge technology merges AI and computer vision…

Read More

ShopMy Raises $70 Million at $1.5 Billion Valuation, Redefining Commerce Through Taste-Driven Curation

In a fresh chapter for creator-driven commerce, ShopMy, the curated commerce infrastructure company, has secured $70 million in a funding round led by Avenir, bringing its valuation to $1.5 billion. This capital injection, bolstered by heavyweight investors including Bain Capital Ventures, Bessemer Venture Partners, Menlo Ventures, and notable individual backers like Sofia Richie and Aimee…

Read More

Glide Identity Raises $20M to Secure the Next Frontier of AI-Enabled Digital Identity

In an era when passwords feel quaint and one-time codes are under siege, Glide Identity has closed a fresh Series A round exceeding $20 million to build what it calls an “authentication layer for the AGI era.” The round was led by Crosspoint Capital Partners, with co‑investment from Amigos Venture Capital, Singtel Innov8 Ventures, and Sir…

Read More

Landmark Credit Union Names Industry Veteran Timothy Mackay as President & CEO Amid Strategic Growth Phase

In a pivotal leadership transition for Wisconsin’s largest credit union, Landmark Credit Union has announced the appointment of Timothy Mackay as its new President and Chief Executive Officer, effective October 13. Mackay succeeds long-serving CEO Jay Magulski, who will retire at the end of the year after 23 years of service, including 12 as president…

Read More

Skild AI Secures $300 Million Series A to Pioneer General-Purpose Robotics

Skild AI, a visionary in the realm of robotics, has marked a significant milestone with the closing of a $300 million Series A funding round. Led by prominent investors including Lightspeed Venture Partners, Coatue, SoftBank Group, and Bezos Expeditions, this funding round values Skild AI at $1.5 billion, underscoring its pivotal role in advancing the…

Read More

Eye Floater Breakthrough! PulseMedica Secures $12 Million CAD to Advance Imaging and Treatment Technology

Good news for anyone experiencing those pesky eye floaters! PulseMedica, a rising star in the life sciences field, has secured $12 million CAD in funding to revolutionize how we diagnose and treat these vision disruptions. This investment fuels the development of their innovative platform, offering a beacon of hope for millions who struggle with these…

Read More

Sonoma Biotherapeutics Secures $45 Million Milestone Payment from Regeneron in Transformative Collaboration

Sonoma Biotherapeutics, Inc., a leading clinical-stage biotechnology firm specializing in engineered regulatory T cell (Treg) therapies, has achieved a significant milestone with a $45 million payment from Regeneron Pharmaceuticals, Inc. This milestone underscores the fruitful partnership between the two companies in developing advanced treatments for autoimmune diseases. The payment marks a pivotal point in Sonoma…

Read More

Mantle Secures $20 Million in Series C Funding to Propel Innovation in Metal 3D Printing Technology

Mantle, a pioneer in precision metal 3D printing for tooling applications, has achieved a significant milestone with the successful closure of a $20 million Series C funding round. This latest investment, led by Schooner Capital and supported by existing investors including Fine Structure Ventures and Foundation Capital, brings Mantle’s total funding to over $61.5 million….

Read More